Clancy Carolyn M
Agency for Healthcare Research and Quality in Rockville, Maryland, USA.
Health Aff (Millwood). 2006 Nov-Dec;25(6):w589-92. doi: 10.1377/hlthaff.25.w589. Epub 2006 Nov 7.
As the United States struggles with improving the return on its sizable health care investment and consumers become increasingly involved in health care decisions, interest in comparative effectiveness will rise because of its relevance to value, personalized health care, quality, and cost containment. Advances in biomedicine and health information technology present exciting opportunities for providing timely, relevant information about the comparative effectiveness of health care services. Successful growth will require a transparent, participatory approach and new partnerships between the public and private sectors to achieve the goal of producing valid evidence for decision making.
在美国努力提高其巨额医疗保健投资回报率且消费者越来越多地参与医疗保健决策之际,由于比较效果与价值、个性化医疗保健、质量及成本控制相关,人们对它的兴趣将会增加。生物医学和健康信息技术的进步为提供有关医疗保健服务比较效果的及时、相关信息带来了令人兴奋的机遇。要实现成功发展,需要采取透明、参与性的方法,并在公共部门和私营部门之间建立新的伙伴关系,以实现为决策提供有效证据的目标。